Pyxis Oncology, Inc. (PYXS)
1.645
-0.04
(-2.66%)
USD |
NASDAQ |
Nov 03, 14:22
Pyxis Oncology Price : 1.645 for Nov. 3, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 02, 2026 | 1.825 | 1.86 | 1.625 | 1.69 | 897376.0 |
| Oct 30, 2026 | 1.88 | 1.885 | 1.78 | 1.81 | 686528.0 |
| Oct 29, 2026 | 1.98 | 1.992 | 1.88 | 1.89 | 697233.0 |
| Oct 28, 2026 | 1.83 | 1.99 | 1.80 | 1.98 | 728124.0 |
| Oct 27, 2026 | 1.70 | 1.85 | 1.68 | 1.84 | 1.184M |
| Oct 26, 2026 | 1.66 | 1.72 | 1.634 | 1.69 | 645784.0 |
| Oct 23, 2026 | 1.70 | 1.71 | 1.63 | 1.68 | 626779.0 |
| Oct 22, 2026 | 1.74 | 1.79 | 1.695 | 1.71 | 557505.0 |
| Oct 21, 2026 | 1.85 | 1.87 | 1.75 | 1.76 | 501331.0 |
| Oct 20, 2026 | 1.76 | 1.90 | 1.73 | 1.84 | 1.111M |
| Oct 19, 2026 | 1.69 | 1.79 | 1.675 | 1.76 | 1.017M |
| Oct 16, 2026 | 1.79 | 1.79 | 1.66 | 1.68 | 908233.0 |
| Oct 15, 2026 | 1.79 | 1.84 | 1.75 | 1.80 | 545754.0 |
| Oct 14, 2026 | 1.82 | 1.88 | 1.735 | 1.79 | 1.559M |
| Oct 13, 2026 | 1.99 | 1.998 | 1.85 | 1.85 | 901747.0 |
| Oct 12, 2026 | 2.03 | 2.08 | 1.99 | 2.01 | 505673.0 |
| Oct 09, 2026 | 1.99 | 2.06 | 1.98 | 2.03 | 950416.0 |
| Oct 08, 2026 | 2.03 | 2.03 | 1.902 | 1.99 | 1.097M |
| Oct 07, 2026 | 2.02 | 2.086 | 2.00 | 2.01 | 957973.0 |
| Oct 06, 2026 | 2.22 | 2.22 | 2.00 | 2.02 | 1.405M |
| Oct 05, 2026 | 2.12 | 2.260 | 2.05 | 2.24 | 1.517M |
| Oct 02, 2026 | 2.21 | 2.31 | 2.10 | 2.14 | 2.000M |
| Oct 01, 2026 | 2.31 | 2.31 | 2.19 | 2.19 | 2.605M |
| Sep 30, 2026 | 2.375 | 2.41 | 2.12 | 2.33 | 8.150M |
| Sep 29, 2026 | 2.94 | 2.94 | 2.83 | 2.90 | 335463.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cypherpunk Technologies, Inc. | 2.56 |
| Cue Biopharma, Inc. | 19.73 |
| Yarrow Bioscience, Inc. | 17.00 |
| Faeth Therapeutics, Inc. | 19.74 |
| Indaptus Therapeutics, Inc. | 3.29 |
Price Related Metrics
| PS Ratio | 9.415 |
| Price to Book Value | 9.122 |
| Earnings Yield | -85.31% |
| Market Cap | 104.35M |